Quantitative Prognostic Analysis of Upper Limb Motor Dysfunction After Stroke
Launched by FU XING HOSPITAL, CAPITAL MEDICAL UNIVERSITY · Jun 4, 2022
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to better understand and predict recovery from upper limb motor dysfunction after a stroke. About 30% to 66% of stroke survivors experience difficulty using their arms, and effective rehabilitation can help them recover. However, resources for rehabilitation can be limited, so the goal of this study is to find out how to evaluate a patient's recovery potential early on and create personalized rehabilitation plans based on their specific needs. The researchers will include 178 stroke patients who have experienced their first stroke and have upper limb dysfunction.
To participate, individuals must be between 18 and 80 years old, have stable conditions, and their stroke must have occurred less than three weeks prior to joining the study. Throughout the trial, participants will undergo various evaluations of their arm function at different time points (one month, three months, and six months after the stroke). The study will also use advanced imaging techniques to look at brain connections related to movement. This research aims to provide valuable insights that can help improve rehabilitation strategies and ensure that resources are used effectively for those recovering from stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • First stroke with upper limb motor dysfunction, Stable condition; 18 ≤age≤80 years old; The onset time was less than 3 weeks at the time of enrollment; Sign informed consent.
- Exclusion Criteria:
- • Stroke patients with intracranial infection, multi-system atrophy and other central nervous system diseases; Combined with severe aphasia, visual spatial neglect and other cognitive impairment; Untreated spasm (Ashworth ≥ grade 2); Obvious joint contracture restricting the movement of upper limb; In vivo metal implants; Claustrophobia.
About Fu Xing Hospital, Capital Medical University
Fu Xing Hospital, affiliated with Capital Medical University, is a leading medical institution dedicated to advancing healthcare through rigorous clinical research and innovative patient care. Renowned for its commitment to medical excellence, the hospital fosters a collaborative environment that integrates clinical practice, education, and research. With a focus on ethical standards and patient safety, Fu Xing Hospital actively engages in a diverse range of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. The institution's strong academic foundation and experienced research team contribute to its reputation as a trusted sponsor in the clinical trial landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Lirong Huo
Study Director
Fu Xing Hospital, Capital Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials